{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:24:38Z","timestamp":1784939078669,"version":"3.55.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.josat.2024.209381","type":"journal-article","created":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T16:32:33Z","timestamp":1714062753000},"page":"209381","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Mining clinical data for novel medications to treat alcohol use disorder"],"prefix":"10.1016","volume":"163","author":[{"given":"Luke","family":"Rozema","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica E.","family":"Hoyt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley V.","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Shiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.josat.2024.209381_bb0005","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1053\/j.gastro.2006.02.023","article-title":"Alcohol use and treatment of hepatitis C virus: Results of a national multicenter study","volume":"130","author":"Anand","year":"2006","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.josat.2024.209381_bb0010","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/pst.433","article-title":"Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies","volume":"10","author":"Austin","year":"2011","journal-title":"Pharmaceutical Statistics"},{"issue":"12","key":"10.1016\/j.josat.2024.209381_bb0015","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1002\/sim.2328","article-title":"A comparison of propensity score methods: A case-study estimating the effectiveness of post-AMI statin use","volume":"25","author":"Austin","year":"2006","journal-title":"Statistics in Medicine"},{"issue":"3","key":"10.1016\/j.josat.2024.209381_bb0020","doi-asserted-by":"crossref","first-page":"215","DOI":"10.7326\/M15-0406","article-title":"Restrictions for Medicaid reimbursement of Sofosbuvir for the treatment of hepatitis C virus infection in the United States","volume":"163","author":"Barua","year":"2015","journal-title":"Annals of Internal Medicine"},{"issue":"Database issue","key":"10.1016\/j.josat.2024.209381_bb0025","doi-asserted-by":"crossref","first-page":"D1083","DOI":"10.1093\/nar\/gkt1031","article-title":"The ChEMBL bioactivity database: An update","volume":"42","author":"Bento","year":"2014","journal-title":"Nucleic Acids Research"},{"issue":"7","key":"10.1016\/j.josat.2024.209381_bb0030","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1111\/j.1530-0277.2007.00403.x","article-title":"AUDIT-C as a brief screen for alcohol misuse in primary care","volume":"31","author":"Bradley","year":"2007","journal-title":"Alcoholism, Clinical and Experimental Research"},{"issue":"10","key":"10.1016\/j.josat.2024.209381_bb0035","first-page":"597","article-title":"Implementation of evidence-based alcohol screening in the veterans health administration","volume":"12","author":"Bradley","year":"2006","journal-title":"The American Journal of Managed Care"},{"issue":"3","key":"10.1016\/j.josat.2024.209381_bb0040","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s40265-021-01670-3","article-title":"Novel agents for the pharmacological treatment of alcohol use disorder","volume":"82","author":"Burnette","year":"2022","journal-title":"Drugs"},{"issue":"9","key":"10.1016\/j.josat.2024.209381_bb0045","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.35715","article-title":"Alcohol use and sustained Virologic response to hepatitis C virus direct-acting antiviral therapy","volume":"6","author":"Cartwright","year":"2023","journal-title":"JAMA Network Open"},{"issue":"4","key":"10.1016\/j.josat.2024.209381_bb0050","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/add.12079","article-title":"Prospective correlates of drinking cessation: Variation across the life-course","volume":"108","author":"Dawson","year":"2013","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.josat.2024.209381_bb0055","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/alcalc\/agn094","article-title":"Transitions in and out of alcohol use disorders: Their associations with conditional changes in quality of life over a 3-year follow-up interval","volume":"44","author":"Dawson","year":"2009","journal-title":"Alcohol and Alcoholism"},{"issue":"8","key":"10.1016\/j.josat.2024.209381_bb0060","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/j.1530-0277.2011.01716.x","article-title":"A double-blind, placebo-controlled trial assessing the efficacy of levetiracetam extended-release in very heavy drinking alcohol-dependent patients","volume":"36","author":"Fertig","year":"2012","journal-title":"Alcoholism, Clinical and Experimental Research"},{"issue":"10","key":"10.1016\/j.josat.2024.209381_bb0065","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1111\/add.13423","article-title":"The burden of alcohol use disorders in US military veterans: Results from the National Health and Resilience in Veterans Study","volume":"111","author":"Fuehrlein","year":"2016","journal-title":"Addiction"},{"issue":"8","key":"10.1016\/j.josat.2024.209381_bb0070","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1001\/jamapsychiatry.2015.0584","article-title":"Epidemiology of DSM-5 alcohol use disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions III","volume":"72","author":"Grant","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"10.1016\/j.josat.2024.209381_bb0075","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3810\/pgm.2013.07.2684","article-title":"Risks, management, and monitoring of combination opioid, benzodiazepines, and\/or alcohol use","volume":"125","author":"Gudin","year":"2013","journal-title":"Postgraduate Medicine"},{"issue":"8","key":"10.1016\/j.josat.2024.209381_bb0080","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1001\/jamapsychiatry.2021.1271","article-title":"Use of medications for alcohol use disorder in the US: Results from the 2019 National Survey on Drug Use and Health","volume":"78","author":"Han","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"12","key":"10.1016\/j.josat.2024.209381_bb0085","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.46604","article-title":"Association between alcohol use disorder and receipt of direct-acting antiviral hepatitis C virus treatment","volume":"5","author":"Haque","year":"2022","journal-title":"JAMA Network Open"},{"issue":"7","key":"10.1016\/j.josat.2024.209381_bb0090","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1001\/archpsyc.64.7.830","article-title":"Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"64","author":"Hasin","year":"2007","journal-title":"Archives of General Psychiatry"},{"issue":"6","key":"10.1016\/j.josat.2024.209381_bb0095","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/aje\/kwaa288","article-title":"Active surveillance of the safety of medications used during pregnancy","volume":"190","author":"Huybrechts","year":"2021","journal-title":"American Journal of Epidemiology"},{"issue":"9370","key":"10.1016\/j.josat.2024.209381_bb0100","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0140-6736(03)13370-3","article-title":"Oral topiramate for treatment of alcohol dependence: A randomised controlled trial","volume":"361","author":"Johnson","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.josat.2024.209381_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172838","article-title":"The effects of dopamine D4 receptor ligands on operant alcohol self-administration and cue- and stress-induced reinstatement in rats","volume":"867","author":"Kim","year":"2020","journal-title":"European Journal of Pharmacology"},{"issue":"11","key":"10.1016\/j.josat.2024.209381_bb0110","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1111\/add.15980","article-title":"Association of topiramate prescribed for any indication with reduced alcohol consumption in electronic health record data","volume":"117","author":"Kranzler","year":"2022","journal-title":"Addiction"},{"key":"10.1016\/j.josat.2024.209381_bb0115","series-title":"TreeScan user guide, v2.1","author":"Kulldorff","year":"2022"},{"issue":"5","key":"10.1016\/j.josat.2024.209381_bb0120","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/pds.3423","article-title":"Drug safety data mining with a tree-based scan statistic","volume":"22","author":"Kulldorff","year":"2013","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"2","key":"10.1016\/j.josat.2024.209381_bb0125","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/1541-0420.00039","article-title":"A tree-based scan statistic for database disease surveillance","volume":"59","author":"Kulldorff","year":"2003","journal-title":"Biometrics"},{"key":"10.1016\/j.josat.2024.209381_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.116851","article-title":"Discovery of potent dual ligands for dopamine D4 and sigma1 receptors","volume":"69","author":"Levoin","year":"2022","journal-title":"Bioorganic & Medicinal Chemistry"},{"issue":"3","key":"10.1016\/j.josat.2024.209381_bb0135","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1530-0277.2011.01649.x","article-title":"A double-blind, placebo-controlled trial to assess the efficacy of quetiapine fumarate XR in very heavy-drinking alcohol-dependent patients","volume":"36","author":"Litten","year":"2012","journal-title":"Alcoholism, Clinical and Experimental Research"},{"issue":"1","key":"10.1016\/j.josat.2024.209381_bb0140","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2174\/187152710790966641","article-title":"Acamprosate: A prototypic neuromodulator in the treatment of alcohol dependence","volume":"9","author":"Mason","year":"2010","journal-title":"CNS & Neurological Disorders Drug Targets"},{"issue":"D1","key":"10.1016\/j.josat.2024.209381_bb0145","doi-asserted-by":"crossref","first-page":"D930","DOI":"10.1093\/nar\/gky1075","article-title":"ChEMBL: Towards direct deposition of bioassay data","volume":"47","author":"Mendez","year":"2019","journal-title":"Nucleic Acids Research"},{"issue":"4","key":"10.1016\/j.josat.2024.209381_bb0150","doi-asserted-by":"crossref","first-page":"436","DOI":"10.15288\/jsad.2020.81.436","article-title":"Remission from unhealthy drinking among patients with an alcohol use disorder: A longitudinal study using systematic, primary care-based alcohol screening data","volume":"81","author":"Palzes","year":"2020","journal-title":"Journal of Studies on Alcohol and Drugs"},{"key":"10.1016\/j.josat.2024.209381_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.109240","article-title":"Epidemiology of DSM-5 alcohol use disorder in U.S. military veterans: Results from the National Health and Resilience in Veterans Study","volume":"231","author":"Panza","year":"2022","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.josat.2024.209381_bb0160","first-page":"344","article-title":"The association between health changes and cessation of alcohol consumption","volume":"52","author":"Park","year":"2017","journal-title":"Alcohol and Alcoholism"},{"issue":"5","key":"10.1016\/j.josat.2024.209381_bb0165","doi-asserted-by":"crossref","first-page":"720","DOI":"10.7326\/M21-4011","article-title":"The management of substance use disorders: synopsis of the 2021 U.S. Department of Veterans Affairs and U.S. Department of Defense clinical practice guideline","volume":"175","author":"Perry","year":"2022","journal-title":"Annals of Internal Medicine"},{"issue":"2","key":"10.1016\/j.josat.2024.209381_bb0170","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/00952990.2018.1528265","article-title":"State-of-the-art behavioral and pharmacological treatments for alcohol use disorder","volume":"45","author":"Ray","year":"2019","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"issue":"3","key":"10.1016\/j.josat.2024.209381_bb0175","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/acer.13953","article-title":"Association between gabapentin receipt for any indication and alcohol use disorders identification test-consumption scores among clinical subpopulations with and without alcohol use disorder","volume":"43","author":"Rentsch","year":"2019","journal-title":"Alcoholism, Clinical and Experimental Research"},{"issue":"8","key":"10.1016\/j.josat.2024.209381_bb0180","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1111\/acer.12092","article-title":"AUDIT-C scores as a scaled marker of mean daily drinking, alcohol use disorder severity, and probability of alcohol dependence in a U.S. general population sample of drinkers","volume":"37","author":"Rubinsky","year":"2013","journal-title":"Alcoholism, Clinical and Experimental Research"},{"issue":"4","key":"10.1016\/j.josat.2024.209381_bb0185","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/acer.13981","article-title":"A prospective study of health conditions related to alcohol consumption cessation among 97,852 drinkers aged 45 and over in Australia","volume":"43","author":"Sarich","year":"2019","journal-title":"Alcoholism, Clinical and Experimental Research"},{"issue":"1","key":"10.1016\/j.josat.2024.209381_bb0190","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/0269881107082944","article-title":"Asenapine: A novel psychopharmacologic agent with a unique human receptor signature","volume":"23","author":"Shahid","year":"2009","journal-title":"Journal of Psychopharmacology"},{"issue":"8623","key":"10.1016\/j.josat.2024.209381_bb0195","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(88)92890-5","article-title":"Alcohol and mortality in British men: Explaining the U-shaped curve","volume":"2","author":"Shaper","year":"1988","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.josat.2024.209381_bb0200","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.biopsych.2021.10.008","article-title":"Mining clinical data for novel posttraumatic stress disorder medications","volume":"91","author":"Shiner","year":"2022","journal-title":"Biological Psychiatry"},{"issue":"4","key":"10.1016\/j.josat.2024.209381_bb0205","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s10865-020-00176-9","article-title":"Recent trends in the rural-urban suicide disparity among veterans using VA health care","volume":"44","author":"Shiner","year":"2021","journal-title":"Journal of Behavioral Medicine"},{"issue":"6","key":"10.1016\/j.josat.2024.209381_bb0210","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.genhosppsych.2014.07.009","article-title":"The provision of mental health treatment after screening: Exploring the relationship between treatment setting and treatment intensity","volume":"36","author":"Shiner","year":"2014","journal-title":"General Hospital Psychiatry"},{"issue":"1","key":"10.1016\/j.josat.2024.209381_bb0215","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.coph.2005.11.003","article-title":"The mechanisms of action of gabapentin and pregabalin","volume":"6","author":"Sills","year":"2006","journal-title":"Current Opinion in Pharmacology"},{"issue":"1","key":"10.1016\/j.josat.2024.209381_bb0220","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.pbb.2005.03.013","article-title":"The selective dopamine D3 receptor antagonist SB-277011-A attenuates ethanol consumption in ethanol preferring (P) and non-preferring (NP) rats","volume":"81","author":"Thanos","year":"2005","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"key":"10.1016\/j.josat.2024.209381_bb0225","series-title":"VA\/DoD CPG for the management of SUDs","author":"The Management of Substance Use Disorders Work Group","year":"2015"},{"issue":"4546","key":"10.1016\/j.josat.2024.209381_bb0230","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1126\/science.7071604","article-title":"Human aldehyde dehydrogenase: Mechanism of inhibition of disulfiram","volume":"216","author":"Vallari","year":"1982","journal-title":"Science"},{"issue":"13","key":"10.1016\/j.josat.2024.209381_bb0235","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1096\/fj.06-6110com","article-title":"The dopamine D3 receptor plays an essential role in alcohol-seeking and relapse","volume":"20","author":"Vengeliene","year":"2006","journal-title":"The FASEB Journal"},{"issue":"3\u20134","key":"10.1016\/j.josat.2024.209381_bb0240","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3109\/00952997509005661","article-title":"Naltrexone pharmacology, pharmacokinetics, and metabolism: Current status","volume":"2","author":"Verebey","year":"1975","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"issue":"1\u20132","key":"10.1016\/j.josat.2024.209381_bb0245","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.drugalcdep.2010.05.008","article-title":"Alcohol impairs interferon signaling and enhances full cycle hepatitis C virus JFH-1 infection of human hepatocytes","volume":"112","author":"Ye","year":"2010","journal-title":"Drug and Alcohol Dependence"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875924000936?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875924000936?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T04:44:36Z","timestamp":1718599476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875924000936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":49,"alternative-id":["S2949875924000936"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2024.209381","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mining clinical data for novel medications to treat alcohol use disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2024.209381","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"209381"}}